Kaboom! CR Pharma listing fetches $1.8bn
China Resources Pharmaceutical Group priced its Hong Kong IPO near the middle of expectations on Friday morning, raising HK$14bn ($1.8bn) after investors stormed into the trade.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: